During the past decade, Froedtert and the Medical College of Wisconsin conducted 289 clinical trials. In the 10-year time frame, 289 clinical trials started and 159 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 141 clinical trials started and 95 clinical trials were completed. i.e. 67.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Froedtert and the Medical College of Wisconsin" #1 sponsor was "Medical College of Wisconsin" with 96 trials, followed by "National Cancer Institute (NCI)" with 33 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "Gynecologic Oncology Group" with 13 trials sponsored and "Alliance for Clinical Trials in Oncology" with 13 trials sponsored. Other sponsors include 271 different institutions and companies that sponsored additional 172 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Froedtert and the Medical College of Wisconsin" #1 collaborator was "National Cancer Institute (NCI)" with 74 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 14 trials as a collaborator, "Radiation Therapy Oncology Group" with 10 trials as a collaborator and "Genentech, Inc." with 6 trials as a collaborator. Other collaborators include 226 different institutions and companies that were collaborators in the rest 179 trials.

According to Clinical.Site data, the most researched conditions in "Froedtert and the Medical College of Wisconsin" are "Multiple Myeloma" (19 trials), "Acute Myeloid Leukemia" (13 trials), "Prostate Cancer" (12 trials), "Lymphoma" (9 trials) and "Refractory Chronic Lymphocytic Leukemia" (9 trials). Many other conditions were trialed in "Froedtert and the Medical College of Wisconsin" in a lesser frequency.

Most popular intervention types in "Froedtert and the Medical College of Wisconsin" are "Drug" (315 trials), "Other" (98 trials), "Biological" (78 trials), "Radiation" (51 trials) and "Device" (39 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Laboratory Biomarker Analysis" (33 trials), "Bevacizumab" (17 trials), "Paclitaxel" (17 trials) and "Cyclophosphamide" (16 trials). Other intervention names were less common.

The vast majority of trials in "Froedtert and the Medical College of Wisconsin" are 384 trials for "All" genders, 45 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are 173 active trials in "Froedtert and the Medical College of Wisconsin". 4 are not yet recruiting, 102 are recruiting, 65 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 186 completed trials in Froedtert and the Medical College of Wisconsin, undefined suspended trials, and 64 terminated clinical trials to date.

Out of the total trials that were conducted in Froedtert and the Medical College of Wisconsin, 90 "Phase 1" clinical trials were conducted, 185 "Phase 2" clinical trials and 125 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 49 trials that are defined as “Not Applicable".

Froedtert and the Medical College of Wisconsin has several departments that took part in Clinical trials: "Froedtert West Bend Hospital/Kraemer Cancer Center" - 43 trials, "Community Memorial Hospital Cancer Care Center" - 16 trials, "Wisconsin Clinical Cancer Center" - 6 trials